Home LiteratureArticle Details
PMID: 9860936 Published · ppublish English Comment Journal Article Review

New insights into the tumor suppression function of P27(kip1)

Proceedings of the National Academy of Sciences of the United States of America ·Vol. 95 ·No. 26 ·1998-12-22 ·Pages 15158-60

Clurman BE, Porter P

Abstract

暂无摘要

MeSH Terms
Animals Cell Cycle Proteins Chromosome Mapping Chromosomes, Human, Pair 16 Chromosomes, Human, Pair 9 Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinases/antagonists & inhibitors Genes, Tumor Suppressor Humans Mice Mice, Knockout Microtubule-Associated Proteins/genetics,physiology Rats Rats, Mutant Strains Tuberous Sclerosis/genetics Tumor Suppressor Proteins
Chemicals
Cdkn1b protein, mouse Cdkn1b protein, rat Cell Cycle Proteins Microtubule-Associated Proteins Tumor Suppressor Proteins Cyclin-Dependent Kinase Inhibitor p27 Cyclin-Dependent Kinases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Clurman B E
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Porter P
References (53)
53 references, click to expand
  1. Inhibitors of mammalian G1 cyclin-dependent kinases.
    Genes Dev. 1995 May 15;9(10):1149-63 PMID: 7758941
  2. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer.
    Nat Genet. 1995 Jan;9(1):70-4 PMID: 7704028
  3. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
    Science. 1995 Aug 4;269(5224):682-5 PMID: 7624798
  4. Translational control of p27Kip1 accumulation during the cell cycle.
    Science. 1996 Mar 29;271(5257):1861-4 PMID: 8596954
  5. p27/Kip1 mutation found in breast cancer.
    Cancer Res. 1996 May 15;56(10):2400-4 PMID: 8625318
  6. Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells.
    Nature. 1996 Mar 21;380(6571):262-5 PMID: 8637577
  7. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle.
    Science. 1996 May 10;272(5263):877-80 PMID: 8629023
  8. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.
    Cell. 1996 May 31;85(5):707-20 PMID: 8646779
  9. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).
    Cell. 1996 May 31;85(5):721-32 PMID: 8646780
  10. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.
    Cell. 1996 May 31;85(5):733-44 PMID: 8646781
  11. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
    Nature. 1996 Jul 25;382(6589):325-31 PMID: 8684460
  12. Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients.
    Hum Mol Genet. 1996 Feb;5(2):249-56 PMID: 8824881
  13. The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase.
    EMBO J. 1996 Oct 1;15(19):5280-9 PMID: 8895573
  14. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients.
    Nat Med. 1997 Feb;3(2):222-5 PMID: 9018243
  15. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.
    Nat Med. 1997 Feb;3(2):227-30 PMID: 9018244
  16. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.
    Nat Med. 1997 Feb;3(2):231-4 PMID: 9018245
  17. Aberrant p27kip1 expression in endocrine and other tumors.
    Am J Pathol. 1997 Feb;150(2):401-7 PMID: 9033255
  18. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2.
    Genes Dev. 1997 Feb 15;11(4):492-503 PMID: 9042862
  19. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis.
    J Biol Chem. 1997 Mar 7;272(10):6097-100 PMID: 9045618
  20. Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest.
    J Biol Chem. 1997 Mar 14;272(11):7093-8 PMID: 9054402
  21. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
    Cancer Res. 1997 Apr 1;57(7):1259-63 PMID: 9102210
  22. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
    Nature. 1997 May 22;387(6631):422-6 PMID: 9163430
  23. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes.
    Oncogene. 1997 May 22;14(20):2373-81 PMID: 9188852
  24. Cyclin E-CDK2 is a regulator of p27Kip1.
    Genes Dev. 1997 Jun 1;11(11):1464-78 PMID: 9192873
  25. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1.
    Mol Cell Biol. 1997 Jul;17(7):3850-7 PMID: 9199319
  26. Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.
    Am J Pathol. 1997 Jul;151(1):151-60 PMID: 9212741
  27. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.
    Science. 1997 Aug 8;277(5327):805-8 PMID: 9242607
  28. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.
    Cancer Res. 1997 Aug 15;57(16):3381-5 PMID: 9270000
  29. Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts.
    Mol Cell Biol. 1997 Sep;17(9):5348-58 PMID: 9271412
  30. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
    EMBO J. 1997 Sep 1;16(17):5322-33 PMID: 9311992
  31. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    EMBO J. 1997 Sep 1;16(17):5334-44 PMID: 9311993
  32. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.
    Hum Mol Genet. 1997 Nov;6(12):2155-61 PMID: 9328481
  33. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase.
    J Biol Chem. 1997 Nov 14;272(46):29301-8 PMID: 9361010
  34. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes.
    Oncogene. 1997 Nov 20;15(21):2561-76 PMID: 9399644
  35. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
    Cancer Res. 1998 Feb 1;58(3):542-8 PMID: 9458103
  36. Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial dysplasia and carcinoma of the oral cavity.
    Am J Pathol. 1998 Feb;152(2):585-90 PMID: 9466585
  37. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
    Cancer Res. 1998 Apr 15;58(8):1730-5 PMID: 9563491
  38. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products.
    Hum Mol Genet. 1998 Jun;7(6):1053-7 PMID: 9580671
  39. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Oncogene. 1998 May;16(20):2575-83 PMID: 9632134
  40. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma.
    J Natl Cancer Inst. 1998 Jun 17;90(12):916-20 PMID: 9637141
  41. Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival.
    Am J Pathol. 1998 Jul;153(1):305-12 PMID: 9665492
  42. A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1).
    EMBO J. 1998 Oct 15;17(20):5987-97 PMID: 9774342
  43. The murine gene p27Kip1 is haplo-insufficient for tumour suppression.
    Nature. 1998 Nov 12;396(6707):177-80 PMID: 9823898
  44. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.
    Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15653-8 PMID: 9861025
  45. Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer.
    Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):327-31 PMID: 8419937
  46. Identification and characterization of the tuberous sclerosis gene on chromosome 16.
    Cell. 1993 Dec 31;75(7):1305-15 PMID: 8269512
  47. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
    Genes Dev. 1994 Jan;8(1):9-22 PMID: 8288131
  48. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.
    Nat Genet. 1994 Feb;6(2):193-6 PMID: 8162074
  49. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity.
    J Biol Chem. 1995 Jul 7;270(27):16409-14 PMID: 7608212
  50. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
    Cell. 1994 Jul 15;78(1):67-74 PMID: 8033213
  51. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene.
    Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11413-6 PMID: 7972075
  52. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias.
    Cancer Res. 1995 Mar 15;55(6):1206-10 PMID: 7882309
  53. p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.
    Cancer Res. 1995 Mar 15;55(6):1211-4 PMID: 7882310
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
DOI
10.1073/pnas.95.26.15158
Published
1998-12-22
Pages
15158-60
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC33928
Subset
IM
Corrections
CommentOn
PMID: 9861025
External Links
PubMed source DOI: 10.1073/pnas.95.26.15158 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2